Predictors of state-of-the-art management of early breast cancer in Switzerland

Annals of Oncology

Volumn 22, Issue 3, 2011, Pages 618-624

  Ess, S ^a   Joerger, M ^a,b   Frick, H ^c   Probst Hensch, N ^d,e   Vlastos, G ^f   Rageth, C ^g   Lutolf U ^h   Savidan, A ^a   Thurlimann B ^b  

^a Cancer Registry St Gallen Appenzell   (Switzerland)

^b CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^c KANTONSSPITAL GRAUBÜNDEN   (Switzerland)

^d Cancer Registry Zurich ^*  (Switzerland)

^e UNIVERSITY OF BASEL   (Switzerland)

^f GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^g Brust Zentrum   (Switzerland)

^h UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Adherence guidelines; Breast cancer; Patterns of care; Practice patterns; Quality; Retrospective study

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER REGISTRY; CANCER STAGING; CANCER SURGERY; COMORBIDITY; EARLY CANCER; FEMALE; GENE OVEREXPRESSION; HEALTH CARE QUALITY; HISTOPATHOLOGY; HUMAN; LIFE EXPECTANCY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MASTECTOMY; PREDICTION; PRIORITY JOURNAL; SOCIOECONOMICS; SWITZERLAND; SYSTEMIC THERAPY; TUMOR VOLUME;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; DISEASE MANAGEMENT; FEMALE; HEALTHCARE DISPARITIES; HUMANS; LOGISTIC MODELS; MIDDLE AGED; MULTIVARIATE ANALYSIS; RURAL HEALTH; SOCIAL CLASS; SWITZERLAND; TREATMENT OUTCOME;

EID: 79952029497     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq404     Document Type: Article

References (49)

1. Bulliard JL, La Vecchia C, Levi F. Diverging trends in breast cancer mortality within Switzerland. Ann Oncol 2006; 17: 57-59.
2. Fisch T, Pury P, Probst N, et al. Variation in survival after diagnosis of breast cancer in Switzerland. Ann Oncol 2005; 16: 1882-1888.
3. Ess S, Savidan A, Frick H, et al. Geographic variation in breast cancer care in Switzerland. Cancer Epidemiol 2010; 34: 116-121.
4. Skinner KA, Helsper JT, Deapen D, et al. Breast cancer: do specialists make a difference? Ann Surg Oncol 2003; 10: 606-615.
5. Morris E, Haward RA, Gilthorpe MS, et al. The impact of the Calman-Hine report on the processes and outcomes of care for Yorkshire's breast cancer patients. Ann Oncol 2008; 19: 284-291.
6. Fong Y, Gonen M, Rubin D, et al. Long-term survival is superior after resection for cancer in high-volume centers. Ann Surg 2005; 242: 540-544; discussion 544-547.
7. Guller U, Safford S, Pietrobon R, et al. High hospital volume is associated with better outcomes for breast cancer surgery: analysis of 233,247 patients. World J Surg 2005; 29: 994-999; discussion 999-1000.
8. Blackman DJ, Masi CM. Racial and ethnic disparities in breast cancer mortality: are we doing enough to address the root causes? J Clin Oncol 2006; 24: 2170-2178.
9. Hebert-Croteau N, Brisson J, Lemaire J, et al. Investigating the correlation between hospital of primary treatment and the survival of women with breast cancer. Cancer 2005; 104: 1343-1348.
10. Gillis CR, Hole DJ. Survival outcome of care by specialist surgeons in breast cancer: a study of 3786 patients in the west of Scotland. BMJ 1996; 312: 145-148.
11. Chaudhry R, Goel V, Sawka C. Breast cancer survival by teaching status of the initial treating hospital. CMAJ 2001; 164: 183-188.
12. Chang JH, Vines E, Bertsch H, et al. The impact of a multidisciplinary breast cancer center on recommendations for patient management: the University of Pennsylvania experience. Cancer 2001; 91: 1231-1237.
13. Varga D, Wischnewsky M, Atassi Z, et al. Does guideline-adherent therapy improve the outcome for early-onset breast cancer patients? Oncology 2010; 78: 189-195.
14. Oecd. OECD review of health systems: Switzerland. OECD Reviews of Health Systems, WHO edition. Paris: OECD Publishing 2006.
15. Swiss Statistical Office. Anteile der Gesundheitskosten am Bruttoinlandprodukt. 14-Gesundheit. Neuchatel and Bern: OECD Health Data 2009.
16. Benz J, Berclaz G, Dupont Lambert V, et al. Tumorektomie oder Mastektomie? Schweizerische Ärztezeitung. SchweizerischeÄrztezeitung 2003; 38: 1956-1966.
17. Benz J, Brun del Re R, Eicher E, et al. Guideline zur Abklä rung des palpablen Mammabefundes. Schweizerische Ärztezeitung 2003; 38: 1947-1955.
18. Zuber M, Oertli D, Marti W, et al. Guideline zur Axilladisektion. Schweizerische Ärztezeitung 2003; 84: 1967-1973.
19. Kurtz J, Bodis S, Gruber S, Huguenin P. Guideline zur postoperativen Radiotherapie des invasiven Mammakarzinoms bei kurativem Behandlungsziel. Schweizerische Ärztezeitung 2003; 38: 1979-1989.
20. Senn H, Thürlimann B, Castiglione-Gertsch M, et al. Guideline zur adjuvanten Systemtherapie (AST) des Mammakarzinoms der Frau. Schweizerische Ärztezeitung 2003; 84: 7.
21. Goldhirsch A, Glick JH, Gelber RD, et al. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. J Clin Oncol 2001; 19: 3817-3827.
22. Goldhirsch A, Wood WC, Gelber RD, et al. Meeting highlights: updated international expert consensus on the primary therapy of early breast cancer. J Clin Oncol 2003; 21: 3357-3365.
23. Rutgers EJ. Quality control in the locoregional treatment of breast cancer. Eur J Cancer 2001; 37: 447-453.
24. Perry NM. Quality assurance in the diagnosis of breast disease. EUSOMA Working Party. Eur J Cancer 2001; 37: 159-172.
25. Kurtz J. The curative role of radiotherapy in the treatment of operable breast cancer. Eur J Cancer 2002; 38: 1961-1974.
26. Guidelines for surgeons in the management of symptomatic breast disease in the United Kingdom. Eur J Surg Oncol 1995; 21 (Suppl A): 1-13.
27. Mirsky D, O'Brien SE, McCready DR, et al. Surgical management of early stage invasive breast cancer (stage I and II). Provincial Breast Disease Site Group. Cancer Prev Control 1997; 1: 10-17.
28. Ess S, Savidan A, Bouchardy C, et al. Patterns of Care of Breast Cancer Patients in Switzerland: A Population Based Study. St Gallen: Krebsforschung Schweiz 2009.
29. Greene FL, Compton CC, Fritz AG, et al. AJCC Cancer Staging Atlas.. New York: John Wiley 2006.
30. Curado MP, Edwards B, H.R. S, et al. Cancer Incidence in Five Continents, vol. IX, IARC Scientific Publications. Lyon: IARC 2007.
31. Parkin DM, Whelan SL, Ferlay J, et al. Cancer Incidence in Five Continents, vol. VIII, IARC Scientific Publications. Lyon: IARC 2002.
32. Tomatis M, Dalmasso M, Del Mastro G, Tomatis AQT. Audit system on breast cancer treatment. CPO Piemonte: European Breast Cancer Network-'Europe Against Cancer' Programme EUSOMA 2006.
33. Tanaka H, Hiyama T, Hanai A, Fujimoto I. Interhospital differences in cancer survival: magnitude and trend in 1975-1987 in Osaka, Japan. Jpn J Cancer Res 1994; 85: 680-685.
34. Lee-Feldstein A, Anton-Culver H, Feldstein PJ. Treatment differences and other prognostic factors related to breast cancer survival. Delivery systems and medical outcomes. JAMA 1994; 271: 1163-1168.
35. Studnicki J, Schapira DV, Bradham DD, et al. Response to the National Cancer Institute Alert. The effect of practice guidelines on two hospitals in the same medical community. Cancer 1993; 72: 2986-2992.
36. Johantgen ME, Coffey RM, Harris DR, et al. Treating early-stage breast cancer: hospital characteristics associated with breast-conserving surgery. Am J Public Health 1995; 85: 1432-1434.
37. Satariano ER, Swanson GM, Moll PP. Nonclinical factors associated with surgery received for treatment of early-stage breast cancer. Am J Public Health 1992; 82: 195-198.
38. Oberaigner W, Stuhlinger W. Influence of department volume on cancer survival for gynaecological cancers-a population-based study in Tyrol, Austria. Gynecol Oncol 2006; 103: 527-534.
39. Leinung S, Schonfelder M, Winzer KJ, et al. [Prospective multicenter study for quality management of breast cancer surgery]. Zentralbl Chir 2003; 128: 493-499.
40. Olivotto A, Coldman AJ, Hislop TG, et al. Compliance with practice guidelines for node-negative breast cancer. J Clin Oncol 1997; 15: 216-222.
41. Raabe NK, Kaaresen R, Fossaa SD. Hospital-related differences in breast cancer management. Analysis of an unselected population-based series of 1353 radically operated patients. Breast Cancer Res Treat 1997; 43: 225-235.
42. Ballard-Barbash R, Potosky AL, Harlan LC, et al. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst 1996; 88: 716-726.
43. Hebert-Croteau N, Brisson J, Latreille J, et al. Variations in the treatment of earlystage breast cancer in Quebec between 1988 and 1994. CMAJ 1999; 161: 951-955.
44. Calman K, Hine D. A Policy Framework for commissioning cancer services: a report by the Expert Advisory Group on Cancer to the Chief Medical Officers of England and Wales 1995.
45. Cataliotti L, Costa A, Daly PA, et al. Florence statement on breast cancer, 1998 forging the way ahead for more research on and better care in breast cancer. Eur J Cancer 1999; 35: 14-15.
46. The requirements of a specialist breast unit. Eur J Cancer 2000; 36: 2288-2293.
47. Switzerland: Statistics of Cancer Incidence 1982-2005. Swiss Association of Cancer Registries 2007.
48. Eikemo TA, Bambra C, Joyce K, Dahl E. Welfare state regimes and incomerelated health inequalities: a comparison of 23 European countries. Eur J Public Health 2008; 18: 593-599.
49. Rothman K, Greenland S. Modern Epidemiology, 2nd edition. Philadelphia, PA: Lippincott-Raven 1998.